Granules India informs about press release

17 Dec 2024 Evaluate
Granules India has informed that it enclosed press release ‘Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the US’.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

592.95 3.25 (0.55%)
18-Dec-2024 13:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1802.65
Dr. Reddys Lab 1275.00
Cipla 1476.50
Lupin 2093.55
Zydus Lifesciences 980.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.